Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,35 USD | -6,37 % | -6,75 % | -20,34 % |
Resumen de negocios
Número de empleados: 74
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Neuroscience and Immuno-oncology Drugs
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +268,00 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +268,00 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Vimal Mehta
FOU | Founder | 63 | 29/03/17 |
Director of Finance/CFO | 66 | 01/10/17 | |
Frank Yocca
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/17 |
Vincent O'Neill
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/07/17 |
Brennan Doyle
IRC | Investor Relations Contact | - | - |
Chetan Lathia
LAW | General Counsel | - | - |
Matthew Wiley
PRN | Corporate Officer/Principal | 52 | 19/01/22 |
Javier Rodriguez
LAW | General Counsel | 52 | 23/02/21 |
55 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 01/07/22 |
Peter Mueller
CHM | Chairman | 68 | 01/04/17 |
Sandeep Laumas
BRD | Director/Board Member | 56 | 01/09/17 |
Vimal Mehta
FOU | Founder | 63 | 29/03/17 |
55 | - | ||
Michal Votruba
BRD | Director/Board Member | 58 | 07/03/19 |
June Bray
BRD | Director/Board Member | 70 | 01/03/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 37 034 517 | 28 002 077 ( 75,61 %) | 0 | 75,61 % |
Información de la empresa
BioXcel Therapeutics, Inc.
555 Long Wharf Drive 12th floor
06511, New Haven
+475 238 6837
http://www.bioxceltherapeutics.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-20,34 % | 92,96 M | |
+10,44 % | 106 mil M | |
+0,82 % | 104 mil M | |
+6,72 % | 23,25 mil M | |
-13,89 % | 22,5 mil M | |
-6,64 % | 18,7 mil M | |
-37,26 % | 17,95 mil M | |
-10,98 % | 16,99 mil M | |
+8,67 % | 14,26 mil M | |
+41,08 % | 12,76 mil M |
- Bolsa de valores
- Acciones
- Acción BTAI
- Empresa BioXcel Therapeutics, Inc.